Stay updated on Checkpoint Blockade in Relapsed Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Checkpoint Blockade in Relapsed Mesothelioma Clinical Trial page.

Latest updates to the Checkpoint Blockade in Relapsed Mesothelioma Clinical Trial page
- Check2 days agoChange DetectedA notice about NIH’s terminology transition appears above the unavailable study record, stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check9 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check16 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the ClinicalTrials.gov 403 error page.SummaryDifference0.2%

- Check37 days agoChange DetectedThe study page now displays a 403 Forbidden error page instead of the study details, with a minimal header/footer shown; the previously available study content and links appear to have been removed, indicating restricted access to the record.SummaryDifference19%

- Check58 days agoChange DetectedThe page adds an NIH grant/contract entry for 2016. It updates the page revision to v3.6.6, removing the previous v3.6.5 revision.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision: v3.6.5 added. A large set of study documents, links, and institutional references (including consent forms, protocol, SAP, IPD sharing information, and the Southampton CTU) were removed from the page, reducing access to key governance and documentation.SummaryDifference17%

Stay in the know with updates to Checkpoint Blockade in Relapsed Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Checkpoint Blockade in Relapsed Mesothelioma Clinical Trial page.